333 related articles for article (PubMed ID: 18317625)
1. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity.
Borges RL; Ribeiro-Filho FF; Carvalho KM; Zanella MT
Arq Bras Cardiol; 2007 Dec; 89(6):409-14. PubMed ID: 18317625
[TBL] [Abstract][Full Text] [Related]
2. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
Bougoulia M; Triantos A; Koliakos G
Hormones (Athens); 2006; 5(4):259-69. PubMed ID: 17178701
[TBL] [Abstract][Full Text] [Related]
3. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; D'Angelo A; Fogari E; Palumbo I; Randazzo S; Cicero AF
Expert Opin Pharmacother; 2010 Aug; 11(12):1971-82. PubMed ID: 20569086
[TBL] [Abstract][Full Text] [Related]
4. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients.
Derosa G; Maffioli P; Ferrari I; D'Angelo A; Fogari E; Palumbo I; Randazzo S; Cicero AF
Fundam Clin Pharmacol; 2011 Oct; 25(5):642-51. PubMed ID: 21077943
[TBL] [Abstract][Full Text] [Related]
5. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.
Valsamakis G; McTernan PG; Chetty R; Al Daghri N; Field A; Hanif W; Barnett AH; Kumar S
Metabolism; 2004 Apr; 53(4):430-4. PubMed ID: 15045687
[TBL] [Abstract][Full Text] [Related]
6. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
[TBL] [Abstract][Full Text] [Related]
7. Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.
Golubović MV; Dimić D; Antić S; Radenković S; Djindjić B; Jovanović M
Vojnosanit Pregl; 2013 Mar; 70(3):284-91. PubMed ID: 23607240
[TBL] [Abstract][Full Text] [Related]
8. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
[TBL] [Abstract][Full Text] [Related]
9. Greater weight loss and hormonal changes after 6 months diet with carbohydrates eaten mostly at dinner.
Sofer S; Eliraz A; Kaplan S; Voet H; Fink G; Kima T; Madar Z
Obesity (Silver Spring); 2011 Oct; 19(10):2006-14. PubMed ID: 21475137
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects.
Al-Tahami BAM; Al-Safi Ismail AA; Sanip Z; Yusoff Z; Shihabudin TMT; Singh TSP; Rasool AHG
J Nippon Med Sch; 2017; 84(3):125-132. PubMed ID: 28724846
[TBL] [Abstract][Full Text] [Related]
11. Orlistat for obesity: benefits beyond weight loss.
Hsieh CJ; Wang PW; Liu RT; Tung SC; Chien WY; Chen JF; Chen CH; Kuo MC; Hu YH
Diabetes Res Clin Pract; 2005 Jan; 67(1):78-83. PubMed ID: 15620437
[TBL] [Abstract][Full Text] [Related]
12. Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.
Bloch KV; Salles GF; Muxfeldt ES; Da Rocha Nogueira A
J Hypertens; 2003 Nov; 21(11):2159-65. PubMed ID: 14597860
[TBL] [Abstract][Full Text] [Related]
13. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.
Tiikkainen M; Bergholm R; Rissanen A; Aro A; Salminen I; Tamminen M; Teramo K; Yki-Järvinen H
Am J Clin Nutr; 2004 Jan; 79(1):22-30. PubMed ID: 14684393
[TBL] [Abstract][Full Text] [Related]
14. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
[TBL] [Abstract][Full Text] [Related]
15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Maffioli P
J Clin Pharm Ther; 2012 Apr; 37(2):187-95. PubMed ID: 21812797
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.
Gannagé-Yared MH; Yaghi C; Habre B; Khalife S; Noun R; Germanos-Haddad M; Trak-Smayra V
Eur J Endocrinol; 2008 Mar; 158(3):353-9. PubMed ID: 18299469
[TBL] [Abstract][Full Text] [Related]
18. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
19. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
[TBL] [Abstract][Full Text] [Related]
20. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.
Ayina CN; Noubiap JJ; Etoundi Ngoa LS; Boudou P; Gautier JF; Mengnjo MK; Mbanya JC; Sobngwi E
Lipids Health Dis; 2016 May; 15():96. PubMed ID: 27189377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
